Target-  | 
MechanismImmunologic cytotoxicity [+1]    | 
Active Org.-  | 
 | 
Active Indication-  | 
 | 
Drug Highest PhaseDiscontinued  | 
First Approval Ctry. / Loc.-  | 
First Approval Date-  | 
Target-  | 
MechanismImmunostimulants   | 
Active Org.-  | 
 | 
Active Indication-  | 
 | 
Drug Highest PhasePending  | 
First Approval Ctry. / Loc.-  | 
First Approval Date-  | 
 | 
MechanismHSPH1 inhibitors   | 
Active Org.-  | 
 | 
Active Indication-  | 
 | 
Drug Highest PhasePending  | 
First Approval Ctry. / Loc.-  | 
First Approval Date-  | 
100 Clinical Results associated with M Group Holdings Ltd.
0  Patents (Medical) associated with M Group Holdings Ltd.
100 Deals associated with M Group Holdings Ltd.
100 Translational Medicine associated with M Group Holdings Ltd.